Bovine leukemia virus (BLV) is the etiologic agent of enzootic bovine leukosis. The virus adopts a strategy based on the lack of viral expression in vivo: only very rare BLV-infected B lymphocytes express viral information. When the cells are isolated from animals in persistent lymphocytosis and cultivated ex vivo, a tremendous increase in viral expression occurs. To gain insight into this mechanism, we employed a general approach using chemicals that interfere specifically with cellular pathways involved in signal transduction from the cell membrane to the nucleus. Our data demonstrate that BLV expression is not correlated with the activity of protein kinase A (PKA) and is even inhibited by cyclic AMP (cAMP). The cAMP/PKA pathway is thus apparently not involved in ex vivo viral expression. In contrast, PKC appears to play a key role in this process. Phorbol myristate acetate can directly activate viral expression in B cells (in the absence of T cells). Furthermore, calphostin C, a highly specific inhibitor of PKC, partly decreases ex vivo BLV expression. Our data further demonstrate that calmodulin and calcineurin, a calmodulin-dependent phosphatase, play a key role in the induction of viral expression. The involvement of this calmodulin-dependent pathway could explain the induction of expression that cannot be assigned to PKC. Furthermore, it appears that the activation of viral expression requires a calmodulin but not a PKA-dependent pathway. These data highlight major differences between transient transfection and ex vivo experiments. Finally, despite their homologies, BLV and human T-cell leukemia virus appear to use different signal transduction pathways to induce viral expression.
Bovine leukemia virus (BLV) is an oncogenic retrovirus associated with enzootic bovine leukosis, a neoplastic proliferation of B cells (4, 5) . The disease is characterized by a persistent lymphocytosis (PL) occurring in more than 30% of BLV-infected cattle. Less than 10% of BLV-infected animals develop lymphosarcoma after extended latency periods. The virus is silent in the majority of the infected cells in vivo. The expression of BLV is thought to be blocked at the transcriptional level, since neither viral proteins nor RNA has been detected in freshly isolated peripheral blood mononuclear cells (PBMCs) or tumor cells (2, 20, 28) . However, since an antiviral humoral response persists in BLV-infected cattle, low-level or transient BLV expression should occur in vivo. This has been confirmed by in situ hybridization experiments (30) . When PBMCs from BLV-infected animals are cultured, the synthesis of readily detectable amounts of BLV RNA, viral proteins, and viral particles occurs (2) . Little is known about the cellular events responsible for the induction of viral expression after in vitro culture. Several lymphocyte activators which can upregulate BLV expression ex vivo have been identified. These activators include fetal calf serum, lipopolysaccharides, antiimmunoglobulin M (IgM) antibodies (30) , lectin mitogen (phytohemagglutinin) (41) , and phorbol esters (25) . This finding suggests that the immune activation of latently infected cells can initiate viral expression in the host. BLV could thus use the cellular machinery involved in the proliferation and differentiation of activated B cells.
Transient transfection experiments have shown that the expression of BLV is regulated at the transcriptional level by a viral protein, Tax, through a triplicate motif of a 21-bp element located in the 5Ј long terminal element (LTR) (called the Tax response element [TxRE] ) (12, 44) . In cell culture, Tax activity appears to be mediated, at least in part, by the bovine CREB2 protein (45) . When a vector expressing CREB2 is transfected in D17 osteosarcoma cells, the CREB2 protein is able to induce BLV LTR expression in the presence of cAMP-dependent protein kinase (protein kinase A [PKA]) (45) . The CREB protein also appears to be a major transcription factor involved in BLV expression in vivo (1a) . This was demonstrated by gel retardation assays using the TxRE probe and ex vivo-isolated BLV-infected B cells. A major complex (called C1) between the TxRE enhancer DNA and CREB appears in BLV-infected B cells from animals in PL. Despite being also present in uninfected cells, this complex is much less abundant in the absence of virus. Together, these data suggest that the cAMP pathway may be involved in BLV expression in vivo. In other systems, the CREB protein can also mediate transcription in response to changes in intracellular Ca 2ϩ concentration (10) . Intracellular Ca 2ϩ influences the cellular metabolism by multiple pathways involving the calmodulin protein.
Calmodulin-dependent kinases (CaM kinases) and phosphatase (calcineurin) have been shown to modulate the transcription of immediate-early genes in PC12 neural cells (14) and the transcription of cytokine genes in T cells (21) . The calcineurin protein is also involved in the activation process of B cells (7, 43) and T cells (13, 37, 39) .
To unravel the mechanisms involved in the activation of BLV expression, we analyzed the effect of chemicals that interfere with the signalling pathways in freshly isolated bovine PBMCs.
RESULTS cAMP inhibits ex vivo expression of BLV.
A triplicate motif of TxRE appears to be the major enhancer involved in BLV expression (12) . Using this element as a probe, we previously isolated the CREB2 protein, which is able to bind specifically to the TxRE DNA (45) . In transient transfection experiments, the CREB2 protein is able to induce BLV LTR expression in the presence of PKA (45) . The CREB protein also appears to be a major transcription factor involved in BLV expression in vivo (1a) . Altogether, these data suggest that the cAMP pathway could be involved in BLV expression in vivo.
We employed a general approach using chemicals that interfere specifically with the cAMP pathway. PBMCs were isolated from a cow (B163) in PL and were cultured in the presence of chemicals that raise cAMP levels. The effects of different concentrations (100, 250, and 500 nM) of dibutyryl cAMP, a liposoluble analog of cAMP, on PBMCs from cow B163 were analyzed (Fig. 1) . After 48 h, the levels of the major capsid protein p24 in the cultured cells were measured by an enzyme-linked immunosorbent assay (ELISA). As shown in Fig. 1 , the liposoluble analog of cAMP reduced the levels of p24 (from 100 to 500 nM) in a dose-dependent manner.
To exclude an indirect effect on non-B cells, the experiments were also performed on B lymphocytes isolated by complement-mediated cell lysis (Fig. 1) . The inhibitory effect of dibutyryl cAMP on p24 expression was even more drastic (from 20 to 60% in B cells, compared with 40 to 80% in PBMCs). Under our experimental conditions, the viability of the cells ranged from 70 to 90%, as demonstrated by trypan blue exclusion. The decrease in p24 expression thus cannot be assigned to a direct toxic effect of dibutyryl cAMP. These data thus indicate that cAMP decreased viral expression in the infected cells.
We next analyzed the effect of cholera toxin, another chemical raising cAMP levels that induces irreversible activation of adenylate cyclase by interacting with the ␣ subunit of G s protein (24) . As observed for dibutyryl cAMP, the expression of BLV as measured by p24 levels was inhibited by cholera toxin FIG. 1. Ex vivo expression of BLV in PBMCs and B cells from one cow in PL (B163) after incubation with two agents that raise cAMP levels. The cells were incubated in the presence of increasing concentrations of dibutyryl cAMP (from 100 to 500 nM) and cholera toxin (from 10 pg/ml to 100 ng/ml). The BLV p24 antigen was titrated in both cell extracts and culture supernatants by ELISA after incubation for 48 h. The data are the mean values obtained from two independent experiments and represent the final percentages compared with a starting point of 100% in the absence of chemical. Standard deviations are indicated.
VOL. 70, 1996 EX VIVO EXPRESSION OF BLV 2171 in a dose-dependent manner (from 30 to 95% in PBMCs and from 10 to 65% B cells, compared with a starting point of 100% in the absence of chemical) (Fig. 1) . The inhibition of BLV expression induced by cholera toxin was even more drastic than the effect of dibutyryl cAMP. Similar data were also obtained for B cells from two other cows in PL (B70 and B77) in duplicate experiments (data not shown).
To correlate cAMP concentrations and viral expression, we determined the cAMP levels in the cells (Fig. 2) . In the absence of any chemical, a kinetic analysis of cAMP levels was performed on PBMCs from cow B163. A high level (4,000 fmol/ml) was observed at the beginning of the culture (10 min) ( Fig. 2A) . Thereafter, the cAMP concentrations decreased to background levels at 48 h. The induction of cAMP in response to the addition of cholera toxin reached a maximum after an incubation time of 120 min. These data demonstrate that cholera toxin indeed increased the cAMP levels, which peaked at 2 h of culture ( Fig. 2A) . The effects of various concentrations of cholera toxin (100 ng/ml to 10 pg/ml) were also analyzed at that time (Fig. 2B ). cAMP levels were strongly activated by cholera toxin at 10 ng/ml but not at 100 pg/ml. Viral expression as measured by p24 levels at 48 h in the same cultures was inversely proportional to the concentration of cholera toxin (in accordance with the results in Fig. 1 ). In other words, viral expression is maximal when cAMP levels reach basal levels and is inhibited when the cAMP concentration increases (Fig. 2B) . Similar results were obtained with use of prostaglandin E 2 , another agent that raises cAMP levels by interaction with the cellular receptor (data not shown).
Viral expression was next correlated with the activation of PKA (Fig. 3) . At a concentration of 10 ng/ml, cholera toxin inhibited p24 expression by more than twofold (compare columns 0 and TC in Fig. 3A) . Simultaneously, cholera toxin induced PKA activity by sixfold (Fig. 3B ). The most specific PKA inhibitor, H89 (15) , was effective in blocking the effects of cholera toxin on PKA (Fig. 3B , column TCϩH89). However, in the experimental conditions used, H89 had no significant effect on BLV expression in the presence of cholera toxin (Fig.  3A) .
Altogether, these data indicate that BLV expression is not correlated with the activity of PKA and is even inhibited by cAMP. The cAMP/PKA pathway is thus apparently not involved in ex vivo viral expression. These data are in opposition to results of transient transfection assays showing that cotransfection of PKA and CREB2 expression vectors activates LTRdirected expression in D17 cells (45) .
Ex vivo BLV expression correlates with the activation of PKC. Binding to the Ig receptor results in the immediate breakdown of phosphatidylinositol biphosphate, leading to the generation of diacylglycerol and inositol triphosphate. Diacylglycerol subsequently triggers the activation of PKC (34) . Crosslinking of B-cell membrane Ig, which mimics the ligation of the Ig receptor, has also been shown to induce the activation of PKC (6) . In the BLV system, direct activation of B cells by an anti-IgM antibody has been reported to induce viral expression (30) . Furthermore, BLV expression is inhibited by a PKC inhibitor (H7) and is activated by the phorbol ester PMA (25) . This finding indicates that the PKC pathway is involved in the ex vivo expression of BLV from PBMCs.
To gain further insight into the involvement of PKC in direct activation of viral expression, we analyzed the effect of PMA in BLV-infected B cells. The B cells were purified by complement-mediated cell lysis from B77 and B163 PBMCs and cultured for 48 h. As shown in Fig. 4 , the addition of PMA (at 0.1 M) induced a three-to fourfold increase of p24 expression compared with the level in unstimulated cells. A similar induction was obtained by anti-IgM cross-linking in PBMCs but not in B cells. T cells are thus required for optimal stimulation even when an activator specific to B cells is used. On the other hand, no difference between PBMCs and B cells was obtained when PKC was directly stimulated by PMA.
We next performed a kinetic analysis of viral expression in the response to either PMA or anti-IgM antibody. PBMCs were cultured for 30 min in the presence of these two PKC activators, washed, resuspended in fresh culture medium, and cultured for 48 h in the absence of activators. These experimental conditions had previously been found to be sufficient to activate viral expression. A kinetic analysis revealed that the activation of BLV expression in response to the anti-IgM antibody FIG. 2. Effect of cAMP levels on BLV expression. The data presented correspond to a representative experiment performed with PBMCs taken from one cow in PL (B163). (A) Kinetic analysis of cAMP production in the absence (0) or presence of cholera toxin (TC). cAMP was titrated by ELISA on cell extracts prepared after increasing incubation times. (B) cAMP production and BLV p24 expression in the presence of increasing concentrations of cholera toxin (from 10 pg/ml to 100 ng/ml). The BLV p24 antigen was titrated in both cell extracts and culture supernatants by ELISA after incubation for 48 h. cAMP was titrated by ELISA on cell extracts prepared after incubation for 2 h. reached a plateau after a 30-min incubation (threefold induction of expression). On the other hand, the activation in response to PMA increased with time (2.7-to 6.7-fold induction). These data demonstrate that the induction of viral expression is linked to the duration of the PMA stimulus (data not shown).
To interfere with the PKC pathway, specific inhibitors were used. The inhibitor H7 was able to selectively inhibit viral expression in a dose-dependent manner (from 10 to 20 M) (Fig. 5A ). An even more drastic inhibition ratio was obtained when the cells were also cultivated in the presence of anti-IgM or PMA (Fig. 5A) . These data are consistent with those of a previous study (25) and indicate that the PKC pathway is involved in BLV expression. However, H7 also inhibits the PKA (K i ϭ 3.0 M) and PKG (K i ϭ 5.8 M) pathways (27) . A much more specific and potent inhibitor of PKC is calphostin C (29) . This chemical also inhibited p24 expression in a dosedependent manner (Fig. 5B) . All of these drug concentrations were consistent with good cell viability in comparison with untreated cells (from 60 to 75% in the presence of 20 M H7 or 100 nM calphostin C).
Altogether, these data confirm and extend the results of a previous study (25) . We now demonstrate that PMA can directly activate viral expression in B cells (in the absence of T cells). Furthermore, calphostin C, a highly specific inhibitor of PKC, also decreases ex vivo BLV expression.
In conclusion, the PKC but not the PKA pathway appears to be involved in the regulation of BLV expression.
Effect of Ca 2؉ influx on ex vivo expression of BLV. Our results on the signalling pathway involved in the induction of BLV expression are puzzling, since the in vivo and in vitro data appear to be in conflict. In transient transfection experiments using D17 cells, PKA activates viral expression through the cellular CREB transcription factor (45) . In similar conditions, we were unable to find a PKC isoform that could enhance BLV expression (our unpublished data). On the other hand, we have previously demonstrated that the CREB protein forms a major complex (C1) with the TxRE enhancer DNA in ex vivo BLVinfected B lymphocytes (1a) . Furthermore, the amounts of the C1 complex correlate with the levels of viral expression. However, the data presented here demonstrate that the cAMP transduction pathway does not activate viral expression. Finally, it seems clear that PKC is involved in this process (reference 25 and this report). It should, however, be mentioned that calphostin C, in contrast to H7, did not completely abrogate BLV expression at concentrations compatible with correct cell viability. Since calphostin C is a much more specific and potent inhibitor of PKC in comparison with H7, it appears that the PKC pathway cannot directly explain all aspects of the induction of viral expression.
Several PKC isoforms can be influenced by the Ca 2ϩ concentration (reviewed in references 11 and 19). To gain insight into a possible role of intracellular Ca 2ϩ , chemicals that interfere with the calcium concentration were analyzed. PBMCs from cow B163 were incubated for 48 h in the presence of increasing concentrations of the Ca 2ϩ ionophore A23187 and thapsigargin, an inhibitor of the Ca 2ϩ /ATPase pump. At a concentration of 1 M, the Ca 2ϩ ionophore was associated with severe toxicity (less than 30% cell viability). At the optimal concentration (0.5 M; cell viability of 70%), A23187 induced a 7.5-fold increase in BLV expression (Fig. 6 ). This stimulation index is even higher than that obtained with the phorbol ester PMA (three-to fourfold) (Fig. 4) . Similar results were obtained FIG. 3 . Ex vivo expression of BLV and PKA activity in PBMCs from one cow in PL (B163) in the presence or absence of cholera toxin (TC; 10 ng/ml) and the PKA inhibitor H89 (50 M). The BLV p24 antigen was titrated in both cell extracts and culture supernatants by ELISA after incubation for 48 h. PKA activity was measured by an in vitro phosphorylation activity assay on cell extracts prepared after incubation for 2 h. The data presented are the mean values obtained from two independent experiments. Standard deviations are indicated. (Fig. 6 ). These data indicate that an increase in intracellular Ca 2ϩ strongly activates viral expression. A major process also depending on intracellular calcium is the calmodulin transduction pathway. To inhibit this pathway, ex vivo PBMC cultures were cultivated in the presence of W7, an antagonist of calmodulin (22) . Incubation with an optimal concentration of W7 induced a 66% decrease of the Ca 2ϩ -stimulated BLV expression ( Fig. 7 ; compare columns A23187 and A23187 ϩ W7). This inhibition is similar to that obtained with the PKC inhibitor calphostin C (Fig. 5 ). These data suggest a possible role for calmodulin in the induction of viral expression.
To further characterize a possible role for calmodulin, chemicals were used to target proteins that are located downstream in the signal transduction pathway, the calmodulindependent kinases. KN-62 is a potent inhibitor of CaM kinase II (42) . At a concentration of 10 M, incubation of PBMCs from cow B163 increased p24 expression by 2.5-fold (Fig. 7) . Furthermore, in the presence of both the calcium ionophore A23187 and the CaM kinase inhibitor KN-62, the stimulation indices peaked at 9.5-fold over the basal level. These results indicate that the inhibition of CaM kinase II increases viral expression.
Another major protein located downstream of calmodulin is calcineurin, a calmodulin-dependent phosphatase. Calcineurin can be strongly inhibited by CsA (40) . When PBMC cultures were incubated in the presence of CsA (at a concentration of 1 g/ml), p24 expression was inhibited twofold (Fig. 7) . Furthermore, CsA had a drastic effect on viral expression in presence of the calcium ionophore A23187 (Fig. 7) . Indeed, the p24 levels fell almost to background levels ( Fig. 7 ; compare columns A23187 and A23187 ϩ CsA). Under these conditions, cell viabilities as measured by trypan blue exclusion were sim- FIG. 5 . Ex vivo expression of BLV after incubation with two inhibitors of PKC, H7 (A) and calphostin C (B). The BLV p24 antigen was titrated in both cell extracts and culture supernatants by ELISA. The data presented correspond to one representative experiment of four performed with PBMCs taken from one cow in PL that were incubated for 1 h with the PKC inhibitors before addition of an anti-IgM antibody (6 g/ml) or PMA (0.1 M) and further incubation for 48 h.
FIG. 6. Ex vivo expression of BLV in
PBMCs from one cow in PL (B163) after incubation with two agents raising intracellular Ca 2ϩ levels. The cells were incubated in the presence of decreasing concentrations of A23187 (from 1,000 to 100 nM) and thapsigargin (from 100 to 1 nM). The BLV p24 antigen was titrated in both cell extracts and culture supernatants by ELISA after incubation for 48 h. The data are the mean values obtained from three independent experiments. Standard deviations are indicated.
FIG. 7. Ex vivo expression of BLV in
PBMCs from one cow in PL in the presence or absence of the Ca 2ϩ ionophore A23187 (0.5 M), the calmodulin inhibitor W7 (25 M), the calmodulin kinases inhibitor KN-62 (10 M), and the calcineurin inhibitor CsA (1 g/ml) . The BLV p24 antigen was titrated in both cell extracts and culture supernatants by ELISA after incubation for 48 h. The data are the mean values obtained from four independent experiments. Standard deviations are indicated. ilar to those obtained in the absence of chemicals (70%). These data are from an experiment performed at least three times and were the same for PBMCs from three other BLVinfected animals.
It thus appears that protein phosphatase calcineurin plays an important role in the ex vivo induction of BLV expression.
DISCUSSION
BLV and human T-cell leukemia virus (HTLV) have many structural and functional homologies. Both viruses belong to a unique family characterized by the lack of expression in vivo. The expression of HTLV requires the cAMP/PKA pathway (16, 24, 26) . Surprisingly, in the BLV system, viral expression is inhibited by cAMP and appears to be independent of PKA in ex vivo cultures. Despite their homologies, BLV and HTLV thus appear to use different signal transduction pathways. Another marked difference concerns the calcium-dependent pathway. In the HTLV system, the calcium ionophore ionomycin reduced viral expression (9) . This is in sharp contrast with our data for the BLV system, which show that A23187 appears to be the most potent activator of viral expression.
It is intriguing that the liposoluble analog of cAMP inhibits BLV expression in ex vivo experiments. The mechanism involved in this process is unknown. However, our data ( Fig. 3) indicate that this inhibition does not directly involve PKA. Several other hypotheses can be advanced. cAMP has been shown to induce differentiation and inhibit proliferation. Indeed, reagents that increase intracellular cAMP block mitogen-induced T-and B-cell proliferation (38) . On the other hand, lymphocyte differentiation seems to be promoted by cAMP (23) . Furthermore, cAMP has also been shown to block phosphatidylinositol turnover in NIH 3T3 cells (33) . In bovine B cells, similar mechanisms could interfere with calcium mobilization following inositol triphosphate synthesis and indirectly inhibit BLV expression.
This report shows that BLV expression is not correlated with the activity of PKA and is even inhibited by cAMP. The cAMP/ PKA pathway is thus apparently not involved in the induction of ex vivo viral expression. These data are consistent with results presented in a previous report (1a) indicating that agents which raise cAMP levels do not modify viral protein synthesis and with gel retardation profiles obtained by using the TxRE probe in ex vivo-isolated BLV-infected B cells. However, the results reported here are in opposition to our transient transfection data showing that cotransfection of PKA and CREB2 expression vectors activate LTR-directed expression in D17 cells (45) . It should be mentioned that in these transient transfections, the PKA-expressing plasmid can be replaced by a CaM kinase IV expression vector (1). In contrast, CaM kinase II strongly inhibits LTR-directed gene expression. The data from this report indicate that KN-62, an inhibitor of CaM kinase II, activated viral expression. In human lymphoid tissues, CaM kinase II is expressed in both B and T cells, whereas CaM kinase IV is found exclusively in T cells. Nevertheless, CaM kinase IV is expressed in primary B cells transformed by Epstein-Barr virus (32) . The induction of this kinase is linked to the viral integral membrane protein 1 (LMP1) of EpsteinBarr virus. Altogether, these data suggest a possible role for the calmodulin-dependent kinase IV, but not II, in BLV expression in vivo.
In addition to this pathway, we have confirmed and extended observations concerning the role of PKC (25) . It should be mentioned that the inhibitor H7 used in that study also inhibits the cAMP and cGMP pathways. A more specific inhibitor, calphostin C, yields a smaller decrease in viral expression, suggesting that factors other than PKC are involved in viral expression. Recently, the BLV LTR was shown to contain an NF-B binding site that was inducible by phorbol esters (3). The metabolic pathway leading to an increase in viral expression could thus involve transcriptional activation by PKC through this element located between the first and second TxRE motifs. However, the mechanism appears complex since phorbol esters also increase the binding to the TxRE elements (1a).
Viral expression is strongly inhibited by CsA, indicating the involvement of calcineurin in this process. Down-regulation of CaM kinase II by calcineurin has been found in neural cells (31) . Furthermore, it has recently been shown that B-cell activation by cross-linking of either membrane Ig, phorbol esters, Ca 2ϩ ionophore, or the CD40 receptor mimicking an activated T-cell contact was linked to the induction of a nuclear factor indistinguishable from the nuclear factor of activated T cells (7, 43) . This induction was inhibited by incubation with CsA and thus correlated with the activity of calcineurin in T cells (8, 35) and in B cells (43) .
Our general strategy using chemicals that interfere specifically with cellular pathways does not elucidate the precise mechanism involved in the regulation of BLV expression. However, the most important regulation is at the transcriptional level. The p24 titers indeed correlate with the amounts of viral RNA levels (data not shown). However, we cannot totally rule out the possibility that the chemicals that we have Taking all these data together, we propose a general model for the induction of BLV expression in ex vivo cultures (Fig. 8) .
The ligation of mlg receptor (or perhaps another stimulus) results in the hydrolysis of phosphatidylinositol, generating inositol triphosphate and diacylglycerol. The diacylglycerol subsequently triggers PKC (6) . Pharmacologic mimicry of these first events by an anti-IgM monoclonal antibody, PMA, and A23187 was indeed followed by an increase of BLV expression (references 1a, 25, and 30 and this report). Our data also show that the inhibition of PKC by H7 and calphostin C was followed by a decrease of viral expression. Inositol triphosphate increases the levels of intracellular Ca 2ϩ by release from the intracellular stores. The stimulus induced by the release of intracellular calcium is transmitted by the Ca 2ϩ receptor calmodulin, which upon binding Ca 2ϩ activates a diversity of enzymes, including multifunctional calmodulin kinases II and IV and the calmodulin phosphatase calcineurin. Our data show that the calmodulin antagonist W7 indeed inhibits viral expression. W7 binds directly to calmodulin and inhibits calmodulinlinked enzyme activities. Therefore, the inhibition of the CaM kinase IV could abolish the phosphorylation of CREB, leading to a decrease of viral expression. We have previously shown that the CaM kinase IV activates LTR-directed gene expression in transient transfection experiments (1) . However, W7 can also indirectly inhibit PKC. Downstream of calmodulin, the calcineurin phosphatase could mediate the down-regulation of CaM kinase II as observed in neural cells (31) . The cyclosporin appears to strongly inhibit BLV viral expression. Since CaM kinase II inhibits LTR-directed gene transcription in transfection experiments (1), calcineurin could indirectly exert an activating effect on viral expression. This hypothesis is supported by the inhibition of CaM kinase II by KN-62, which increases the viral expression.
Although the model that we propose is still speculative, the use of specific chemicals clearly indicates that the calmodulin/ calcineurin pathway is involved in ex vivo BLV expression.
